This company seems to have been delisted
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
ViewRay
VRAY
HK$0.19
Share price
0.00%
Change (1 day)
-99.27%
Change (1 year)
Categories
EPS for ViewRay (VRAY)
EPS in 2023 (TTM): -HK$4.70
According to ViewRay's latest financial reports the company's current EPS (TTM) is -HK$4.66. In 2022 the company made an earnings per share (EPS) of -HK$4.51 an increase over its 2021 EPS that were of -HK$5.21.
EPS history for ViewRay from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -HK$4.70 | 4.37% |
| 2022 | -HK$4.51 | -13.43% |
| 2021 | -HK$5.21 | -9.46% |
| 2020 | -HK$5.75 | -37.29% |
| 2019 | -HK$9.17 | 21.65% |
| 2018 | -HK$7.54 | -23.02% |
| 2017 | -HK$9.79 | -0.79% |
| 2016 | -HK$9.87 | |
| 2014 | -HK$0.03902 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -HK$4.66 | 0.00% | 🇺🇸 USA |
 | HK$5.75 | -223.33% | 🇺🇸 USA |
 | -HK$13.60 | 191.67% | 🇮🇱 Israel |